<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045067"><TermName>XK469R</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of leukemia. It belongs to the family of drugs called topoisomerase inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>XK469R</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la leucemia. Es un tipo de inhibidor de la topoisomerasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2006-10-12</DateLastModified></GlossaryTerm>
